Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
Researchers have discovered a biomarker which predicts whether glioblastoma brain tumors will respond to chemotherapy.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
A new study argues that prolonged chemotherapy decreases the development of new brain cells, and disrupts ongoing brain rhythms in the part of the brain responsible for making new memories.
When aggressive, malignant tumors appear in more than one location in the brain, patient survival tends to be significantly shorter than when the disease starts as a single tumor, even though patients in both groups undergo virtually identical treatments, according to research at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Research Institute.
Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant. For the first...
